Humana | HUM | Long at $220.00Humana NYSE:HUM took a nosedive to "crash" levels (based on my selected simple moving averages (SMA)) this morning after a lower-performance rating for a widely used Medicare insurance plan is expected to hurt enrollments for 2025 (and will potentially hit the health insurer's revenue and bonus payments in 2026). However, I view this massive drop as an opportunity for an initial long entry for a great value stock. The company is strong, highly rated among patients, and solid fundamentals despite the anticipated earnings drop. From a technical analysis perspective, it touched my "crash" SMA, but may dip further after a dead cat bounce to the $190s in the coming days or weeks. But, predicting true bottom is a fool's game, so at $220.00, NYSE:HUM is in a personal buy zone for an initial long entry.
Target #1 = $250.00
Target #2 = $275.00
Target #3 = $314.00
Target #4 = $340.00
Medicare
$CLOV Bearish Channels Breakout upward Incoming$CLOV was consolidating after a retracement down. After consolidation and approaching the edge of a wedge indicating a big movement. They were unexpectedly the target of a short sellers report which caused the movement to continue downward. With a well articulated rebuttal the doc was able to rally and bounce back up. We appear to be at the bottom of a bearish channel and will likely retrace back up in the near future a short squeeze caused by any positive catalyst will likely break the channel upward allowing us to retrace upward towards the $14 area. With February 19th options expiring I expect the retracement to happen soon after.
$CLOV Bullish Wedge, Incoming Break Upwards$CLOV revering and nearing end of bullish wedge pattern. We likely see a nice breakup going into next week. Additionally, the Medicare Advantage Leadership Innovations meeting will be held on January 27, 2021 where they stated they'd announce a previously unannounced partnership. Recently updated 2021 provider lists notes the addition of Costco $COST. So this could be potentially huge news incoming as well as a great catalyst to retrace and retest previous high's.
SHILPA MEDICARE - Pull back or breakoutToday's close suggests that there is more gravity towards a pull back.
After the "Cup and Handle" breakout wait for a pullback to end.
With patience 25% on the cards after it crosses 627 on closing basis.
*****
Help Me to Help Us.
I believe in keeping the chart simple with minimal drawings & easy to interpret.
So kindly express any disagreement & improvements so that we learn & earn together.
Please support the effort and appreciate it with a Like if you felt it deserves it and Following me would only add on to the confidence.